Investing
The company aims to empower physicians with job transparency, financial tools and a peer community to enhance workplace fulfillment and autonomy.
The company will use the funds to support its ongoing clinical trial, ramp up production and sales for its OtoSight Middle Ear Scope and relocate its headquarters.
OneCell Diagnostics scores $16 million for genomics-based precision oncology and dannce.ai, a phenotyping platform to digitize clinical assessments, secures $2.6 million.
Also, an Indian startup has raised $1 million in seed funding to develop dental nanorobots.
The funds will be used to enhance its technology, expand its partnership with payers and providers, scale its reach and accelerate clinical research through enrollment support.
The General Catalyst Institute, launched in the U.S. in September, is expanding into India and inviting policymakers and entrepreneurs in the region to collaborate.
According to Bloomberg, the brain-implant chipmaker raised $93 million in funding, increasing the startup's valuation to approximately $500 million.
HATCo will spend a total of $550 million in capital funding to invest in technologies and innovation.
The company will use the funds to expand in Asian and U.S. markets, advance its AI algorithms and grow its workforce.
The company reported a 77% YOY increase in revenue in Q3 2024 and plans to release a generic version of Novo Nordisk's GLP-1 drug on its platform in 2025.